When persons with diabetes use miscoded blood glucose meters to determine how much insulin to take, significant errors in insulin dose can result that may potentially lead to short- and long-term health complications, according to a new study published in the Journal of Diabetes Science and Technology. The study also showed that meters with "No Coding" technology (meters that automatically set the correct code anytime a test strip is inserted) gave a superior performance over meters used in this study that had been correctly coded manually. This also translated into a lower probability of insulin dose error. Coding is the process by which a blood glucose meter is matched to each new box of test strips being used. For more information, visit
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.